ImmuCell reports mixed Q4 2025 results, pauses Re-Tain development
Go back to ImmuCell reports mixed Q4 2025 results, pauses Re-Tain development| Immucell Corp (NASDAQ: ICCC) | Delayed: 10.98 +0.03 (0.27%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.95 | 52 Week High | $8.29 | |||
| Open | $10.80 | 52 Week Low | $4.99 | |||
| Day High | $11.06 | P/E | 137.25 | |||
| Day Low | $10.47 | EPS | $0.08 | |||
| Volume | 26,829 | |||||

